SNE-101

N/A

Report date: 2025/09/29 14:28:13

Base Information

Drug NameSNE-101
Drug Alias NameSNE-101SNE-101DSNE-101SSNE-101M
ClassificationBiologics > Exosomes > Stem cell-derived exosomesSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionExosome replacements
TargetsUpdating
Therapy Area/IndicationsIschemic StrokeStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesS&E Bio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesS&E Bio Co Ltd
Inactive CompaniesN/A
Active IndicationsIschemic StrokeStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A